- GSK, Novartis create an $11 billion consumer healthcare business
- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- Novartis Consumer Health's return to shelf on track, Theraflu relaunching next
- Novartis names new head of sales U.S.
- Reports: Novartis exits vaccines and animal health while acquiring oncology business from GSK
PARSIPPANY, N.J. — Novartis Consumer Health on Thursday voluntarily issued a recall of certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States prior to Dec. 31, 2011.
The full recall resulted from a faulty child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place.
To see the full listing of recalled products including Lot and NDC numbers, click here.
"We are instructing consumers, our retail partners, and wholesalers to return the products for a full refund," Novartis stated.
Find us on Facebook for more insight, analysis and the latest in drug store news.